NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Enstoa, Inc., the only company that focuses exclusively on accelerated digital transformation for the built environment, today announced the launch of Thrys

PARSIPPANY, N.J., Sept. 17, 2019 /PRNewswire/ -- Bringing back the power of the close doctor-patient relationship and improving access to healthcare is the focus of a new collaborative partnership between the

RANCHO SANTA MARGARITA, Calif., Sept. 17, 2019 /PRNewswire/ -- Luminaries from industry, healthcare and academia are converging at the Leadership in the Age of Personalization® Executive Summit, on October 9, 2019 in Huntington Beach, California, presented

TOWSON, Md., Sept. 17, 2019 /PRNewswire/ -- Apex Physics Partners, provider of business services to medical physicist consulting practices, today announced the promotion of Michele F. Loscocco, MS, DABR, to president of Krueger-Gilbert Health Physics (KGHP). She will have primary responsibility for operating the Mid-Atlantic region serving

DENVER, Sept. 17, 2019 /PRNewswire/ -- Sea turtles suffering from toxic red tide exposure could benefit from a therapy used to treat human drug overdoses. Morris Animal Fo

OVERLAND PARK, Kan., Sept. 17, 2019 /PRNewswire/ -- Intouch Group, a full-service agency network serving the pharmaceutical industry, announced it has earned SOC 2 Type 2 certification, making it among the first pharmaceutical advertising agency networks to achieve such a designation. The network also has earned an independently verified HIPAA/HITECH compliance atte

LONDON, Sept. 17, 2019 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1/stable Moody's and BB+/positive S&P) the multinational pharmaceutical company, has launched a new prefilled syringe capability in the US through its affiliate, Hikma Pharmaceuticals USA Inc.1

NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Happify Health, a global leader in mental health technology, today announced it signed an agreement with global biopharmaceutical company Sanofi (NASDAQ: SNY) to advance the application of digital therapeutics to address key co-morbidities for individuals living with multiple sclerosis (MS), including depression and anxi

BERKELEY, Calif., Sept. 17, 2019 /PRNewswire/ -- This morning, the U.S. Patent and Trademark Office (USPTO) awarded a new CRISPR-Cas9 patent to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering compositions comprising single mole

PHILADELPHIA, Sept. 16, 2019 /PRNewswire/ -- Today at the Heart Failure Society of America Annual Meeting Dr. William T. Abraham the SMILE national principle investigator presented the results of the study as a late breaking trial. The study examined use of ReDS™ non-invasive remote monitoring of pulmonary congestion for the mana